EBSA 2025July 2025Infectious DiseasesAntibodies & BiologicsPoster code 25016

About this poster
This poster presents the generation and biophysical characterization of novel rabbit-derived monoclonal antibodies against the SARS-CoV-2 NSP13 helicase, a highly conserved and essential component of the viral replication complex. These antibodies show high affinity and specificity, and have been validated in Western Blot and immunoassay formats. Their development addresses a critical gap in tools for studying helicase-targeting antivirals, enabling more precise investigation of NSP13 function and mechanism of action in cellular models.
Get the full poster
Free PDF, sent to your work email.
nsp13-mabs poster, code 25016
Related posters
June 2025, code 25013Identification and Biophysical Assessment of mAb AM E3, an Innovative α-TLSPR ADC Candidate Aimed at Treating TLSPR/CRLF2-Rearranged Ph-like B-ALLAntibody Engineering & Therapeutics Europe 2025September 2024, code 24009SPR Technology for the Identification of New Therapeutic Agents from Phage Display LibrariesDIPIASeptember 2026, code 26019Discovery and Characterization of a Brain-Penetrant SHP2 InhibitorDDIP 2026

